Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OMEGA-3 FATTY ACID STUDIES HINDERED BY U.S. DIET RICH IN OMEGA-6

This article was originally published in The Tan Sheet

Executive Summary

OMEGA-3 FATTY ACID STUDIES HINDERED BY U.S. DIET RICH IN OMEGA-6 fatty acids, making it difficult to demonstrate protection against cardiovascular disease in intervention studies, William Lands, PhD, National Institute on Alcohol Abuse and Alcoholism, suggested at an American Heart Association-sponsored scientific conference on omega-3 fatty acids in Houston on April 17-19. Researchers at the conference discussed a number of studies linking omega-3 intake to cardiovascular benefits such as decreased triglyceride levels, lower blood pressure, protection of normal endothelial function and other effects, although some study results were called "equivocal" or "less than compelling."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel